Analyst Reco. Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 12/12/2025 GMT			5-day change	1st Jan Change
2,015.00 ^DKK	-1.52%		-0.84%	+35.01%

12-12	Genmab Finalizes Tender Offer for Dutch Biotech Merus	MT
12-12	Genmab Completes Acquisition of Merus – Bolsters Portfolio with New Cancer Treatment	FW

Analyst Reco.

JP Morgan Raises Genmab Price Target to 2,050 Danish Kroner (from 1,650), Maintains Neutral Rating - BN	12-08	FW
Kepler Cheuvreux Kicks Off Genmab Coverage at Hold	11-14	MT
Genmab advances on earnings strength and pipeline while lower valuation opens upside	11-07
Truist Trims Price Target on Genmab to $48 From $49, Keeps Buy Rating	11-07	MT
Handelsbanken raises target price for Genmab to DKK 2,200 (2,000), reiterates buy recommendation - BN	11-03	FW
Nordea Raises Price Target for Genmab to 2,021 Danish Kroner, Reiterates Buy	10-31	FW
Jyske Bank Downgrades Genmab to Hold	10-29	MT
Jyske Bank Downgrades Genmab to Hold (from Buy), Sets Target Price at 2,000 Danish Kroner - BN	10-28	FW
Goldman Sachs Raises Target Price for Genmab to 1,996 Danish Kroner, Maintains Neutral Rating - BN	10-24	FW
Genmab Shares Drop on J&J Study Data Signaling Heightened Competition	10-20	FW
Genmab A/S Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®?) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer	10-18	CI
Aktiespararna Recommends Buying Genmab Shares	10-17	FW
GENMAB : UBS raises target price	10-06
UBS Raises Price Target for Genmab to 2,700 Danish Kroner, Reiterates Buy	10-06	FW
Deutsche Bank Raises Genmab Target Price to 2,000 Danish Kroner, Reiterates Buy	10-06	FW
Canaccord Quest Updates Buy/Sell List: Truecaller and Betsson Removed from Buys, H&M Off Sells	10-01	FW
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says	09-29	MT
GENMAB : A bold shift from defensive to aggressive	09-29
Sydbank raises Genmab to buy (hold) - BN	09-29	FW
Ålandsbanken: Genmab Pays Too High a Price for Merus	09-29	FW
JP Morgan Raises Target Price for Genmab to 1,650 Danish Kroner (from 1,500), Maintains Neutral Rating - BN	09-11	FW
Bernstein Raises Target Price for Genmab to 1,015 Danish Kroner, Reiterates Underperform	09-08	FW
Deutsche Bank Raises Genmab Price Target to DKK 1,900, Reiterates Buy	08-28	FW
Rothschild Lowers Price Target for Genmab to 2,650 Danish Kroner (from 2,700), Reiterates Buy - BN	08-20	FW
GENMAB : target price raised by UBS	08-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab advances on earnings strength and pipeline while lower valuation opens upside

November 07, 2025 at 03:01 pm

Genmab: From now on, courage to the most patient

April 01, 2025 at 03:57 pm